Annual Operating Expenses
$148.93 M
+$39.47 M+36.06%
31 December 2023
Summary:
Celldex Therapeutics annual total operating expenses is currently $148.93 million, with the most recent change of +$39.47 million (+36.06%) on 31 December 2023. During the last 3 years, it has risen by +$91.94 million (+161.32%). CLDX annual operating expenses is now at all-time high.CLDX Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Expenses
$55.32 M
+$6.50 M+13.32%
01 September 2024
Summary:
Celldex Therapeutics quarterly total operating expenses is currently $55.32 million, with the most recent change of +$6.50 million (+13.32%) on 01 September 2024. Over the past year, it has increased by +$12.56 million (+29.38%). CLDX quarterly operating expenses is now at all-time high.CLDX Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Operating Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +36.1% | +29.4% |
| 3 y3 years | +161.3% | +185.5% |
| 5 y5 years | +73.3% | +281.4% |
CLDX Operating Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +161.3% | at high | +185.5% |
| 5 y | 5 years | at high | +161.3% | at high | +318.0% |
| alltime | all time | at high | +7346.3% | at high | >+9999.0% |
Celldex Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $55.32 M(+13.3%) |
| June 2024 | - | $48.81 M(+19.8%) |
| Mar 2024 | - | $40.76 M(+3.8%) |
| Dec 2023 | $148.93 M(+36.1%) | $39.26 M(-8.2%) |
| Sept 2023 | - | $42.76 M(+27.7%) |
| June 2023 | - | $33.47 M(+0.1%) |
| Mar 2023 | - | $33.44 M(+13.4%) |
| Dec 2022 | $109.45 M(+48.3%) | $29.50 M(+5.0%) |
| Sept 2022 | - | $28.10 M(+0.8%) |
| June 2022 | - | $27.89 M(+16.3%) |
| Mar 2022 | - | $23.97 M(+14.6%) |
| Dec 2021 | $73.80 M(+29.5%) | $20.92 M(+8.0%) |
| Sept 2021 | - | $19.38 M(+16.3%) |
| June 2021 | - | $16.66 M(-1.1%) |
| Mar 2021 | - | $16.84 M(+19.9%) |
| Dec 2020 | $56.99 M(-1.9%) | $14.05 M(-2.1%) |
| Sept 2020 | - | $14.35 M(+8.4%) |
| June 2020 | - | $13.23 M(-13.9%) |
| Mar 2020 | - | $15.36 M(+13.3%) |
| Dec 2019 | $58.10 M(-32.4%) | $13.56 M(-6.5%) |
| Sept 2019 | - | $14.50 M(+3.7%) |
| June 2019 | - | $13.99 M(-12.8%) |
| Mar 2019 | - | $16.05 M(+3.3%) |
| Dec 2018 | $85.94 M(-29.6%) | $15.54 M(-0.6%) |
| Sept 2018 | - | $15.64 M(-42.2%) |
| June 2018 | - | $27.07 M(-2.2%) |
| Mar 2018 | - | $27.69 M(-6.4%) |
| Dec 2017 | $122.07 M(-12.6%) | $29.58 M(+7.6%) |
| Sept 2017 | - | $27.48 M(-13.5%) |
| June 2017 | - | $31.76 M(-4.5%) |
| Mar 2017 | - | $33.25 M(-9.5%) |
| Dec 2016 | $139.70 M(+3.5%) | $36.73 M(+14.0%) |
| Sept 2016 | - | $32.21 M(-4.6%) |
| June 2016 | - | $33.76 M(-8.8%) |
| Mar 2016 | - | $37.01 M(+5.0%) |
| Dec 2015 | $135.02 M(+7.1%) | $35.23 M(+5.5%) |
| Sept 2015 | - | $33.40 M(-4.4%) |
| June 2015 | - | $34.93 M(+11.0%) |
| Mar 2015 | - | $31.47 M(-6.1%) |
| Dec 2014 | $126.02 M(+51.4%) | $33.53 M(+6.6%) |
| Sept 2014 | - | $31.44 M(+7.9%) |
| June 2014 | - | $29.14 M(-8.7%) |
| Mar 2014 | - | $31.91 M(+40.3%) |
| Dec 2013 | $83.22 M(+42.2%) | $22.73 M(-6.2%) |
| Sept 2013 | - | $24.25 M(+29.3%) |
| June 2013 | - | $18.75 M(+7.3%) |
| Mar 2013 | - | $17.48 M(+5.0%) |
| Dec 2012 | $58.50 M(+34.4%) | $16.65 M(+12.0%) |
| Sept 2012 | - | $14.86 M(+9.1%) |
| June 2012 | - | $13.62 M(+1.8%) |
| Mar 2012 | - | $13.38 M(+134.8%) |
| Dec 2011 | $43.55 M(+5.8%) | $5.70 M(-58.8%) |
| Sept 2011 | - | $13.84 M(+39.9%) |
| June 2011 | - | $9.89 M(+2.3%) |
| Mar 2011 | - | $9.67 M(-0.9%) |
| Dec 2010 | $41.17 M(-6.9%) | $9.76 M(-3.6%) |
| Sept 2010 | - | $10.12 M(-3.7%) |
| June 2010 | - | $10.51 M(-2.7%) |
| Mar 2010 | - | $10.79 M(-31.7%) |
| Dec 2009 | $44.24 M(+17.2%) | $15.79 M(+73.3%) |
| Sept 2009 | - | $9.11 M(-9.2%) |
| June 2009 | - | $10.04 M(+8.1%) |
| Mar 2009 | - | $9.29 M(+34.2%) |
| Dec 2008 | $37.74 M(+123.2%) | $6.92 M(-36.7%) |
| Sept 2008 | - | $10.94 M(-11.2%) |
| June 2008 | - | $12.32 M(+62.8%) |
| Mar 2008 | - | $7.57 M(+62.0%) |
| Dec 2007 | $16.91 M(-14.1%) | $4.67 M(+5.1%) |
| Sept 2007 | - | $4.45 M(+28.9%) |
| June 2007 | - | $3.45 M(-20.7%) |
| Mar 2007 | - | $4.35 M(-2214.4%) |
| Dec 2006 | $19.69 M | -$205.60 K(-103.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $6.48 M(-5.1%) |
| June 2006 | - | $6.83 M(+205.3%) |
| Mar 2006 | - | $2.24 M(-54.5%) |
| Dec 2005 | $21.95 M(+7.4%) | $4.91 M(-10.9%) |
| Sept 2005 | - | $5.51 M(-0.6%) |
| June 2005 | - | $5.54 M(+182.8%) |
| Mar 2005 | - | $1.96 M(-69.1%) |
| Dec 2004 | $20.44 M(+24.9%) | $6.34 M(+46.0%) |
| Sept 2004 | - | $4.35 M(-11.1%) |
| June 2004 | - | $4.89 M(-2.2%) |
| Mar 2004 | - | $4.99 M(+33.4%) |
| Dec 2003 | $16.37 M(-22.4%) | $3.74 M(-10.5%) |
| Sept 2003 | - | $4.18 M(-2.1%) |
| June 2003 | - | $4.27 M(+2.6%) |
| Mar 2003 | - | $4.17 M(-5.3%) |
| Dec 2002 | $21.10 M(-24.3%) | $4.40 M(-11.0%) |
| Sept 2002 | - | $4.95 M(-16.9%) |
| June 2002 | - | $5.95 M(+2.7%) |
| Mar 2002 | - | $5.79 M(-28.1%) |
| Dec 2001 | $27.87 M(+65.0%) | $8.05 M(+10.4%) |
| Sept 2001 | - | $7.30 M(+4.7%) |
| June 2001 | - | $6.97 M(+14.7%) |
| Mar 2001 | - | $6.08 M(+6.5%) |
| Dec 2000 | $16.89 M(+19.5%) | $5.71 M(+22.9%) |
| Sept 2000 | - | $4.64 M(+40.5%) |
| June 2000 | - | $3.30 M(+1.9%) |
| Mar 2000 | - | $3.24 M(-19.8%) |
| Dec 1999 | $14.14 M(+34.7%) | $4.04 M(+22.4%) |
| Sept 1999 | - | $3.30 M(-2.9%) |
| June 1999 | - | $3.40 M(-2.9%) |
| Mar 1999 | - | $3.50 M(-2.8%) |
| Dec 1998 | $10.50 M(+14.1%) | $3.60 M(+24.1%) |
| Sept 1998 | - | $2.90 M(+45.0%) |
| June 1998 | - | $2.00 M(0.0%) |
| Mar 1998 | - | $2.00 M(-4.8%) |
| Dec 1997 | $9.20 M(-29.2%) | $2.10 M(-8.7%) |
| Sept 1997 | - | $2.30 M(-14.8%) |
| June 1997 | - | $2.70 M(+22.7%) |
| Mar 1997 | - | $2.20 M(-29.0%) |
| Dec 1996 | $13.00 M(-11.0%) | $3.10 M(+19.2%) |
| Sept 1996 | - | $2.60 M(-44.7%) |
| June 1996 | - | $4.70 M(+80.8%) |
| Mar 1996 | - | $2.60 M(-33.3%) |
| Dec 1995 | $14.60 M(-4.6%) | $3.90 M(+5.4%) |
| Sept 1995 | - | $3.70 M(+8.8%) |
| June 1995 | - | $3.40 M(-5.6%) |
| Mar 1995 | - | $3.60 M(+24.1%) |
| Dec 1994 | $15.30 M(-9.5%) | $2.90 M(-21.6%) |
| Sept 1994 | - | $3.70 M(-15.9%) |
| June 1994 | - | $4.40 M(+2.3%) |
| Mar 1994 | - | $4.30 M(+2.4%) |
| Dec 1993 | $16.90 M(+57.9%) | $4.20 M(-10.6%) |
| Sept 1993 | - | $4.70 M(+9.3%) |
| June 1993 | - | $4.30 M(+4.9%) |
| Mar 1993 | - | $4.10 M(-2.4%) |
| Dec 1992 | $10.70 M(-25.2%) | - |
| Oct 1992 | - | $4.20 M(+20.0%) |
| July 1992 | - | $3.50 M(-14.6%) |
| Apr 1992 | - | $4.10 M(+13.9%) |
| Apr 1992 | $14.30 M(+5.9%) | - |
| Jan 1992 | - | $3.60 M(+2.9%) |
| Oct 1991 | - | $3.50 M(+12.9%) |
| July 1991 | - | $3.10 M(-8.8%) |
| Apr 1991 | $13.50 M(+12.5%) | $3.40 M(+3.0%) |
| Jan 1991 | - | $3.30 M(-2.9%) |
| Oct 1990 | - | $3.40 M(0.0%) |
| July 1990 | - | $3.40 M(+9.7%) |
| Apr 1990 | $12.00 M(+39.5%) | $3.10 M(-8.8%) |
| Jan 1990 | - | $3.40 M |
| Apr 1989 | $8.60 M(+36.5%) | - |
| Apr 1988 | $6.30 M(+61.5%) | - |
| Apr 1987 | $3.90 M(+95.0%) | - |
| Apr 1986 | $2.00 M | - |
FAQ
- What is Celldex Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Celldex Therapeutics?
- What is Celldex Therapeutics annual operating expenses year-on-year change?
- What is Celldex Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly operating expenses year-on-year change?
What is Celldex Therapeutics annual total operating expenses?
The current annual operating expenses of CLDX is $148.93 M
What is the all time high annual operating expenses for Celldex Therapeutics?
Celldex Therapeutics all-time high annual total operating expenses is $148.93 M
What is Celldex Therapeutics annual operating expenses year-on-year change?
Over the past year, CLDX annual total operating expenses has changed by +$39.47 M (+36.06%)
What is Celldex Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of CLDX is $55.32 M
What is the all time high quarterly operating expenses for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly total operating expenses is $55.32 M
What is Celldex Therapeutics quarterly operating expenses year-on-year change?
Over the past year, CLDX quarterly total operating expenses has changed by +$12.56 M (+29.38%)